37 Sex Differences in Chronic Coronary Syndrome: Data from the ILIAS Physiology Registry REFERENCES 1. T.J. Ford, D. Corcoran, C. Berry, Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need, Heart 104 (4) (2018) 284–292. 2. J. Knuuti, W. Wijns, A. Saraste, D. Capodanno, E. Barbato, C. Funck-Brentano, et al., 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes, Eur. Heart J. 41 (3) (2020) 407–477. 3. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 19902013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet 385 (9963) (2015) 117–171. 4. L. Jespersen, A. Hvelplund, S.Z. Abildstrøm, F. Pedersen, S. Galatius, J.K. Madsen, et al., Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events, Eur. Heart J. 33 (6) (2012) 734–744. 5. L.J. Shaw, R.E. Shaw, C.N. Merz, R.G. Brindis, L.W. Klein, B. Nallamothu, et al., Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of CardiologyNational Cardiovascular Data Registry, Circulation 117 (14) (2008) 1787–1801. 6. M.R. Patel, E.D. Peterson, D. Dai, J.M. Brennan, R.F. Redberg, H.V. Anderson, et al., Low diagnostic yield of elective coronary angiography, N. Engl. J. Med. 362 (10) (2010) 886–895. 7. B. Vogel, M. Acevedo, Y. Appelman, C.N. Bairey Merz, A. Chieffo, G.A. Figtree, et al., The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030, Lancet 397 (10292) (2021) 2385–2438. 8. B.D. Johnson, L.J. Shaw, S.D. Buchthal, C.N. Bairey Merz, H.W. Kim, K.N. Scott, et al., Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the national institutes of health-national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation (WISE), Circulation 109 (24) (2004) 2993–2999. 9. E. Jones, W. Eteiba, N.B. Merz, Cardiac syndrome X and microvascular coronary dysfunction, Trends Cardiovasc. Med. 22 (6) (2012) 161–168. 10. T.P. van de Hoef, J.M. Lee, C.K.M. Boerhout, G.A. de Waard, J.H. Jung, S.H. Lee, et al., Combined assessment of FFR and CFR for decision making in coronary revascularization: from the multicenter international ILIAS registry, JACC Cardiovasc. Interv. 15 (10) (2022) 1047–1056. 11. N.H. Pijls, B. De Bruyne, K. Peels, P.H. Van Der Voort, H.J. Bonnier, J.K.J. J. Bartunek, et al., Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses, N. Engl. J. Med. 334 (26) (1996) 1703–1708. 12. O.M. Demir, C.K.M. Boerhout, G.A. de Waard, T.P. van de Hoef, N. Patel, M.A. M. Beijk, et al., Comparison of Doppler flow velocity and thermodilution derived indexes of coronary physiology, JACC Cardiovasc. Interv. 15 (10) (2022) 1060–1070. 13. R.G.T. Feenstra, A. Seitz, C.K.M. Boerhout, R.J. de Winter, P. Ong, M.A.M. Beijk, et al., Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index, Int. J. Cardiol. 371 (2023) 16–20. 14. F. Crea, R.A. Montone, R. Rinaldi, Pathophysiology of coronary microvascular dysfunction, Circ. J. 86 (9) (2022) 1319– 1328. 2
RkJQdWJsaXNoZXIy MTk4NDMw